SlideShare a Scribd company logo
Net news

I suffered from this disease a couple of years back. i had severe joint pains and also fever. I
consulted a doctor, was given medicines. I took them regularly . The fever stopped but the
joint pain was much after that. I suffered for nearly 6 months with the pain. One cannot stand
erect after sitting for sometime. It is very dfficult actually. I could resume routine only after 6-8
months. Pain killers on the advise of the dr. is best. Also you could ask your mil to take lots of
oranges, it may help.

Chikungunya virus (CHIKV) is responsible for major epidemics worldwide. Autochthonous cases
were recently reported in several European countries. Acute infection is thought to be
monophasic. However reports on chronic pain related to CHIKV infection have been made. In
particular, the fact that many of these patients do not respond well to usual analgesics suggests
that the nature of chronic pain may be not only nociceptive but also neuropathic. Neuropathic
pain syndromes require specific treatment and the identification of neuropathic characteristics
(NC) in a pain syndrome is a major step towards pain control.

The mean intensity of pain on the visual-analogical scale (VAS) was 5.8 ± 2.1, and its mean
duration was 89 ± 2 days. Fifty-six patients fulfilled the definition of chronic pain. Pain had NC in
18.9% according to the DN4 questionnaire. Conversely, about two thirds (65%) of patients with
NC had chronic pain. The average pain intensity was similar between patients with or without
NC (6.0 ± 1.7 vs 6.1 ± 2.0). However, the total score of the Short Form-McGill Pain
Questionnaire (SF-MPQ)(15.5 ± 5.2 vs 11.6 ± 5.2; p < 0.01) and both the affective (18.8 ± 6.2 vs
13.4 ± 6.7; p < 0.01) and sensory subscores (34.3 ± 10.7 vs 25.0 ± 9.9; p < 0.01) were
significantly higher in patients with NC. The mean pain interference in life activities calculated
from the Brief Pain Inventory (BPI) was significantly higher in patients with chronic pain than in
patients without it (6.8 ± 1.9 vs 5.9 ± 1.9, p < 0.05). This score was also significantly higher in
patients with NC than in those without such a feature (7.2 ± 1.5 vs 6.1 ± 1.9, p < 0.05).

Chikungunya (in the Makonde language "that which bends up") virus (CHIKV) is an insect-
borne virus, of the genus Alphavirus, that is transmitted to humans by virus-
carrying Aedesmosquitoes.[1] There have been recent outbreaks of CHIKV associated with
severe illness. CHIKV causes an illness with symptoms similar to dengue fever. CHIKV
manifests itself with an acutefebrile phase of the illness lasting only two to five days, followed by
a prolonged arthralgic disease that affects the joints of the extremities. The pain associated with
CHIKV infection of the joints persists for weeks or months, or in some cases years.[2][3]

The incubation period of Chikungunya disease is from two to four days. Symptoms of the
disease include a fever up to 40 °C (104 °F), apetechial or maculopapular rash of the trunk and
occasionally the limbs, and arthralgia or arthritis affecting multiple joints.[4] Other nonspecific
symptoms can include headache, conjunctival Injection, and slight photophobia. Typically, the
fever lasts for two days and then ends abruptly. However, other symptoms—namely joint pain,
intense headache, insomnia and an extreme degree of prostration—last for a variable period;
usually for about 5 to 7 days.[4] Patients have complained of joint pains for much longer time
periods depending on their age.[5][6]

Post-Epidemic Chikungunya Disease on Reunion Island: Course of Rheumatic Manifestations
and Associated Factors over a 15-Month Period
At the 15-month-period evaluation after diagnosis, 84 of 147 participants (57%) self-reported
rheumatic symptoms. Of these 84 patients, 53 (63%) reported permanent trouble while 31
(37%) had recurrent symptoms. Age ≥45 years (OR = 3.9, 95% CI 1.7–9.7), severe initial joint
pain (OR = 4.8, 95% CI 1.9–12.1), and presence of underlying osteoarthritis comorbidity (OR =
2.9, 95% CI 1.1–7.4) were predictors of nonrecovery. Our findings suggest that long-term
CHIKV rheumatic manifestations seem to be a frequent underlying post-epidemic condition.
Three independent risk factors that may aid in early recognition of patients with the highest risk
of presenting prolonged CHIKV illness were identified. Such findings may be particularly useful
in the development of future prevention and care strategies for this emerging virus infection.

 We found that rheumatic symptoms lasted for at least 15 months in 57% of the participants. Of
these, 63% reported permanent trouble while 37% had recurrent symptoms. Factors such as
age ≥45 years, severe initial joint pain, and presence of underlying osteoarthritis comorbidity
were associated with nonrecovery over the 15-month period. Our findings suggest that long-
term CHIKV rheumatic manifestations seem to be a hidden, frequent, post-epidemic condition.
These findings should be considered in the development of preventive measures.

Chikungunya fever, an emerging mosquito-borne viral disease,
has affected Mauritius with two recent outbreaks in 2005 and 2006
respectively. A study was carried out in 2007 to describe the clinical
complications post-Chikungunya infection. Ethical clearance was obtained for
this study. Data collection was carried out in February and March 2007 on a
sample of people who had suffered from Chikungunya fever by means of a
comprehensive questionnaire. Participants comprised 77 people; there were 41
males and 36 females. Participants ranged from 6 to 69 years. 70 participants
experienced persisting joint pains for at least 6 months following the acute
phase. Of these, 35 had residual joint complaints after 6 months. 44
participants suffered from psychological sequelae. 10 participants had
dermatological sequelae, 6 had iatrogenic complications due to non-steroidal
anti-inflammatory drug (NSAID)-induced gastritis, and 3 participants with
serologically confirmed Chikungunya fever had neurological manifestations
and changes on CT/MRI which could correspond to demyelination. Statistical
analysis demonstrated that there was a weak linear relationship between the
number of complications and increasing age; there was a significant difference
in the number of complications according to gender, females being more
affected than males; participants with co-morbidities had more complications
and psychological sequelae than previously healthy participants. This study
highlights that Chikungunya fever, which causes a significant impact on health
in the acute phase, can have significant sequelae months afterwards and this
includes psychological sequelae.
Chikungunya or unknown viral fever

I have Chikungunya fever during December 2009. Doctor describes it as viral fever and give
some medicines. Fever gone but the pain persists even after three months. The fever is
having all the symptoms that are described in net sites.

The Chikungunya will be there only for three or four days. My fever has gone on fourth day.

It will reach 104 degrees. I have 104 degrees for two days.

Chikungunya ends abruptly for ordinary medicines. I have taken paracetamol and declofenac
and the fever ends.

Rheumatic pain will be there even upto six months. I am still have pain even after three
months.

It is epidemic and spreads quickly. During december and january in my town alone each and
every house has four or five patients.

But doctors say this is not Chikungunya but an unknown viral fever. Government doctors also
repeat the same. One doctor describes it as a cross breeding of denque and Chikungunya.

So it is undoubtedly the notorius Chikungunya. But even the newspapers and TV channels
describe it as unknown viral fever. Government declares that there is an unidentified viral fever
and it is not Chikungunya and research is going on to find what it is.

But according to common men who is standing with the knee bending it is Chikungunya and say
“I am having Chikungunya for the past three months” when they describe their sufferings.

My doubt is why the media and the Government hesitate to declare that it is Chikungunya.

Whether the World Health Organisation (W.H.O) will declare the country as ugly country if it has
Chikungunya?

Or whether the World Bank will refuse to give loans to the country if Chikungunya is there in that
country?

Or whether the opposing party members will cry that the Government has failed to control an
epidemic decease in Parliament and in Assembly?

God only knows.....

But the pain and the doubt persist............

More Related Content

What's hot

Disease situation update__jalozai_id_ps_(week_48_2012)_031212
Disease situation update__jalozai_id_ps_(week_48_2012)_031212Disease situation update__jalozai_id_ps_(week_48_2012)_031212
Disease situation update__jalozai_id_ps_(week_48_2012)_031212
Muhammad Ishtiaq
 
New Concept Of Kawasaki Disease By Ho-Chang Kuo 2008(川崎症)郭和昌醫師
New Concept Of Kawasaki Disease By Ho-Chang Kuo 2008(川崎症)郭和昌醫師New Concept Of Kawasaki Disease By Ho-Chang Kuo 2008(川崎症)郭和昌醫師
New Concept Of Kawasaki Disease By Ho-Chang Kuo 2008(川崎症)郭和昌醫師
Ho-Chang Kuo (郭和昌 醫師)
 
05NTD 2022 - UPDATES IN VECTOR CONTROL IN MALAYSIA: What is new?
05NTD 2022 - UPDATES IN VECTOR CONTROL IN MALAYSIA:  What is new?05NTD 2022 - UPDATES IN VECTOR CONTROL IN MALAYSIA:  What is new?
05NTD 2022 - UPDATES IN VECTOR CONTROL IN MALAYSIA: What is new?
Institute for Clinical Research (ICR)
 
Factors Underlying Indivdual Differential Sleepiness in OSA
Factors Underlying Indivdual Differential Sleepiness in OSAFactors Underlying Indivdual Differential Sleepiness in OSA
Factors Underlying Indivdual Differential Sleepiness in OSA
Leonard Davis Institute of Health Economics
 
Grosberg 2007 NH Paper - Pareja comments
Grosberg 2007 NH Paper - Pareja commentsGrosberg 2007 NH Paper - Pareja comments
Grosberg 2007 NH Paper - Pareja comments
dschwar1
 
japanese encephalitis
japanese encephalitisjapanese encephalitis
japanese encephalitisSiti Mastura
 
4th Issue of CRC Perak Network Bulletin (2021)
4th Issue of CRC Perak Network Bulletin (2021)4th Issue of CRC Perak Network Bulletin (2021)
4th Issue of CRC Perak Network Bulletin (2021)
Institute for Clinical Research (ICR)
 
Exploding Head Syndrome
Exploding Head SyndromeExploding Head Syndrome
Exploding Head Syndrome
Ade Wijaya
 
Scripps lj grand rounds
Scripps lj grand roundsScripps lj grand rounds
Scripps lj grand rounds
3GDR
 
Martin duddy, drugs on the horizon
Martin duddy, drugs on the horizonMartin duddy, drugs on the horizon
Martin duddy, drugs on the horizon
MS Trust
 
Pediatrics in Review (February 2013)
Pediatrics in Review (February 2013)Pediatrics in Review (February 2013)
Pediatrics in Review (February 2013)Alfredo Torralbas
 
Journal club: Chronic urticaria and autoimmunity
Journal club: Chronic urticaria and autoimmunityJournal club: Chronic urticaria and autoimmunity
Journal club: Chronic urticaria and autoimmunity
Chulalongkorn Allergy and Clinical Immunology Research Group
 
03.18.2016 landazuri rse and ncse
03.18.2016 landazuri rse and ncse03.18.2016 landazuri rse and ncse
03.18.2016 landazuri rse and ncse
Ayagoz Umbetzhanova
 
Restricción de dieta en migraña, basada en la medición de anticuperpos ig g.
Restricción de dieta en migraña, basada en la medición de anticuperpos ig g.Restricción de dieta en migraña, basada en la medición de anticuperpos ig g.
Restricción de dieta en migraña, basada en la medición de anticuperpos ig g.
MEDIAGNOSTIC
 
Systemic steroids in preschool children with recurrent wheezing exacerbations
Systemic steroids in preschool children with recurrent wheezing exacerbationsSystemic steroids in preschool children with recurrent wheezing exacerbations
Systemic steroids in preschool children with recurrent wheezing exacerbations
Envicon Medical Srl
 
Ctg underlying pathophysiology
Ctg underlying pathophysiologyCtg underlying pathophysiology
Ctg underlying pathophysiologyDr P Deepak
 
NSAIDs hypersensitivity
NSAIDs hypersensitivityNSAIDs hypersensitivity
06NTD 2022 - Managing Dengue in Children: an update
06NTD 2022 - Managing Dengue in Children: an update06NTD 2022 - Managing Dengue in Children: an update
06NTD 2022 - Managing Dengue in Children: an update
Institute for Clinical Research (ICR)
 
Comparative Outcomes of C difficile infected patients with NAP1 v non NAP1 st...
Comparative Outcomes of C difficile infected patients with NAP1 v non NAP1 st...Comparative Outcomes of C difficile infected patients with NAP1 v non NAP1 st...
Comparative Outcomes of C difficile infected patients with NAP1 v non NAP1 st...Benjamin (Ben) Cottongim
 
GI CANCER SCREENING
GI CANCER SCREENINGGI CANCER SCREENING
GI CANCER SCREENING
ChernHaoChong
 

What's hot (20)

Disease situation update__jalozai_id_ps_(week_48_2012)_031212
Disease situation update__jalozai_id_ps_(week_48_2012)_031212Disease situation update__jalozai_id_ps_(week_48_2012)_031212
Disease situation update__jalozai_id_ps_(week_48_2012)_031212
 
New Concept Of Kawasaki Disease By Ho-Chang Kuo 2008(川崎症)郭和昌醫師
New Concept Of Kawasaki Disease By Ho-Chang Kuo 2008(川崎症)郭和昌醫師New Concept Of Kawasaki Disease By Ho-Chang Kuo 2008(川崎症)郭和昌醫師
New Concept Of Kawasaki Disease By Ho-Chang Kuo 2008(川崎症)郭和昌醫師
 
05NTD 2022 - UPDATES IN VECTOR CONTROL IN MALAYSIA: What is new?
05NTD 2022 - UPDATES IN VECTOR CONTROL IN MALAYSIA:  What is new?05NTD 2022 - UPDATES IN VECTOR CONTROL IN MALAYSIA:  What is new?
05NTD 2022 - UPDATES IN VECTOR CONTROL IN MALAYSIA: What is new?
 
Factors Underlying Indivdual Differential Sleepiness in OSA
Factors Underlying Indivdual Differential Sleepiness in OSAFactors Underlying Indivdual Differential Sleepiness in OSA
Factors Underlying Indivdual Differential Sleepiness in OSA
 
Grosberg 2007 NH Paper - Pareja comments
Grosberg 2007 NH Paper - Pareja commentsGrosberg 2007 NH Paper - Pareja comments
Grosberg 2007 NH Paper - Pareja comments
 
japanese encephalitis
japanese encephalitisjapanese encephalitis
japanese encephalitis
 
4th Issue of CRC Perak Network Bulletin (2021)
4th Issue of CRC Perak Network Bulletin (2021)4th Issue of CRC Perak Network Bulletin (2021)
4th Issue of CRC Perak Network Bulletin (2021)
 
Exploding Head Syndrome
Exploding Head SyndromeExploding Head Syndrome
Exploding Head Syndrome
 
Scripps lj grand rounds
Scripps lj grand roundsScripps lj grand rounds
Scripps lj grand rounds
 
Martin duddy, drugs on the horizon
Martin duddy, drugs on the horizonMartin duddy, drugs on the horizon
Martin duddy, drugs on the horizon
 
Pediatrics in Review (February 2013)
Pediatrics in Review (February 2013)Pediatrics in Review (February 2013)
Pediatrics in Review (February 2013)
 
Journal club: Chronic urticaria and autoimmunity
Journal club: Chronic urticaria and autoimmunityJournal club: Chronic urticaria and autoimmunity
Journal club: Chronic urticaria and autoimmunity
 
03.18.2016 landazuri rse and ncse
03.18.2016 landazuri rse and ncse03.18.2016 landazuri rse and ncse
03.18.2016 landazuri rse and ncse
 
Restricción de dieta en migraña, basada en la medición de anticuperpos ig g.
Restricción de dieta en migraña, basada en la medición de anticuperpos ig g.Restricción de dieta en migraña, basada en la medición de anticuperpos ig g.
Restricción de dieta en migraña, basada en la medición de anticuperpos ig g.
 
Systemic steroids in preschool children with recurrent wheezing exacerbations
Systemic steroids in preschool children with recurrent wheezing exacerbationsSystemic steroids in preschool children with recurrent wheezing exacerbations
Systemic steroids in preschool children with recurrent wheezing exacerbations
 
Ctg underlying pathophysiology
Ctg underlying pathophysiologyCtg underlying pathophysiology
Ctg underlying pathophysiology
 
NSAIDs hypersensitivity
NSAIDs hypersensitivityNSAIDs hypersensitivity
NSAIDs hypersensitivity
 
06NTD 2022 - Managing Dengue in Children: an update
06NTD 2022 - Managing Dengue in Children: an update06NTD 2022 - Managing Dengue in Children: an update
06NTD 2022 - Managing Dengue in Children: an update
 
Comparative Outcomes of C difficile infected patients with NAP1 v non NAP1 st...
Comparative Outcomes of C difficile infected patients with NAP1 v non NAP1 st...Comparative Outcomes of C difficile infected patients with NAP1 v non NAP1 st...
Comparative Outcomes of C difficile infected patients with NAP1 v non NAP1 st...
 
GI CANCER SCREENING
GI CANCER SCREENINGGI CANCER SCREENING
GI CANCER SCREENING
 

Viewers also liked

Luke 1:26-35 -Bryan Thomson
Luke 1:26-35 -Bryan ThomsonLuke 1:26-35 -Bryan Thomson
Luke 1:26-35 -Bryan Thomsonsajsaj
 
The power of example
The power of exampleThe power of example
The power of example
Janet Huang
 
Dengue fever ppt(1)
Dengue fever ppt(1)Dengue fever ppt(1)
Dengue fever ppt(1)
afzalnaeem
 
Dengue fever
Dengue feverDengue fever
Dengue feverbhabilal
 
DENGUE FEVER
DENGUE FEVERDENGUE FEVER
DENGUE FEVERicsp
 
Project proposal
Project proposalProject proposal
Project proposal
Jayson Patalinghug
 
Dengue Fever Power Point
Dengue Fever Power PointDengue Fever Power Point
Dengue Fever Power Point
orlandito12
 

Viewers also liked (8)

Luke 1:26-35 -Bryan Thomson
Luke 1:26-35 -Bryan ThomsonLuke 1:26-35 -Bryan Thomson
Luke 1:26-35 -Bryan Thomson
 
The power of example
The power of exampleThe power of example
The power of example
 
Dhf
DhfDhf
Dhf
 
Dengue fever ppt(1)
Dengue fever ppt(1)Dengue fever ppt(1)
Dengue fever ppt(1)
 
Dengue fever
Dengue feverDengue fever
Dengue fever
 
DENGUE FEVER
DENGUE FEVERDENGUE FEVER
DENGUE FEVER
 
Project proposal
Project proposalProject proposal
Project proposal
 
Dengue Fever Power Point
Dengue Fever Power PointDengue Fever Power Point
Dengue Fever Power Point
 

Similar to Chikungunya

Predicting transition to chronic pain.
Predicting transition to chronic pain.Predicting transition to chronic pain.
Predicting transition to chronic pain.
Paul Coelho, MD
 
Chik-V and PSA elevation_Publication_CRU
Chik-V and PSA elevation_Publication_CRUChik-V and PSA elevation_Publication_CRU
Chik-V and PSA elevation_Publication_CRUWilliam Aiken
 
Diagnosis and Management of Chronic pain associated with depression.pptx
Diagnosis and Management of Chronic pain associated with depression.pptxDiagnosis and Management of Chronic pain associated with depression.pptx
Diagnosis and Management of Chronic pain associated with depression.pptx
ssuser40df77
 
Dolor lumbar inespecífico
Dolor lumbar inespecíficoDolor lumbar inespecífico
Dolor lumbar inespecífico
María Alejandra Bermeo Losada
 
Vulvodynia article - edited final version.docx
Vulvodynia article - edited final version.docxVulvodynia article - edited final version.docx
Vulvodynia article - edited final version.docx
Kavinda Hewawitharana
 
learn to solve several cases in low back pain
learn to solve several cases in low back painlearn to solve several cases in low back pain
learn to solve several cases in low back pain
HERRY632019
 
Riu008001 0028
Riu008001 0028Riu008001 0028
Riu008001 0028Jonny Luna
 
Neuropathic pain: an overview
Neuropathic pain: an overviewNeuropathic pain: an overview
Neuropathic pain: an overview
University of the Witwatersrand
 
00006250 201409000-00021
00006250 201409000-0002100006250 201409000-00021
00006250 201409000-00021Jonny Luna
 
PCP AC 2021 - Back Pain Basics
PCP AC 2021 - Back Pain BasicsPCP AC 2021 - Back Pain Basics
PCP AC 2021 - Back Pain Basics
Allan Corpuz
 
Central Neuropathic Pain after Acute Spinal Cord Injury (NP in SCI): A Case s...
Central Neuropathic Pain after Acute Spinal Cord Injury (NP in SCI): A Case s...Central Neuropathic Pain after Acute Spinal Cord Injury (NP in SCI): A Case s...
Central Neuropathic Pain after Acute Spinal Cord Injury (NP in SCI): A Case s...
International Multispeciality Journal of Health
 
Lynna Nguyen, Final Paper
Lynna Nguyen, Final PaperLynna Nguyen, Final Paper
Lynna Nguyen, Final PaperLynna Nguyen
 
Predicting Medical Test Results and Intra-Operative Findings in Chronic Pain ...
Predicting Medical Test Results and Intra-Operative Findings in Chronic Pain ...Predicting Medical Test Results and Intra-Operative Findings in Chronic Pain ...
Predicting Medical Test Results and Intra-Operative Findings in Chronic Pain ...
Nelson Hendler
 
Neuropathic pain: epidemiology, risks and prevention
Neuropathic pain: epidemiology, risks and preventionNeuropathic pain: epidemiology, risks and prevention
Neuropathic pain: epidemiology, risks and prevention
University of the Witwatersrand
 
Experience of a comprehensive pain care (cpc) clinic from a provincial gener...
Experience of a comprehensive pain care (cpc) clinic  from a provincial gener...Experience of a comprehensive pain care (cpc) clinic  from a provincial gener...
Experience of a comprehensive pain care (cpc) clinic from a provincial gener...
Rohitha Jayamaha
 
Impact of migraine_on_fibromyalgia_symptoms
Impact of migraine_on_fibromyalgia_symptomsImpact of migraine_on_fibromyalgia_symptoms
Impact of migraine_on_fibromyalgia_symptoms
Paul Coelho, MD
 
Aidp dilemmas
Aidp dilemmasAidp dilemmas
Aidp dilemmas
DR RML DELHI
 
Chikv zikv autoimmunity_f
Chikv zikv autoimmunity_fChikv zikv autoimmunity_f
Chikv zikv autoimmunity_f
anayajm
 
Meta-Analysis of population studies on the prevalence of chronic pain in UK –...
Meta-Analysis of population studies on the prevalence of chronic pain in UK –...Meta-Analysis of population studies on the prevalence of chronic pain in UK –...
Meta-Analysis of population studies on the prevalence of chronic pain in UK –...
Pubrica
 

Similar to Chikungunya (20)

Predicting transition to chronic pain.
Predicting transition to chronic pain.Predicting transition to chronic pain.
Predicting transition to chronic pain.
 
Chik-V and PSA elevation_Publication_CRU
Chik-V and PSA elevation_Publication_CRUChik-V and PSA elevation_Publication_CRU
Chik-V and PSA elevation_Publication_CRU
 
Diagnosis and Management of Chronic pain associated with depression.pptx
Diagnosis and Management of Chronic pain associated with depression.pptxDiagnosis and Management of Chronic pain associated with depression.pptx
Diagnosis and Management of Chronic pain associated with depression.pptx
 
Dolor lumbar inespecífico
Dolor lumbar inespecíficoDolor lumbar inespecífico
Dolor lumbar inespecífico
 
Vulvodynia article - edited final version.docx
Vulvodynia article - edited final version.docxVulvodynia article - edited final version.docx
Vulvodynia article - edited final version.docx
 
learn to solve several cases in low back pain
learn to solve several cases in low back painlearn to solve several cases in low back pain
learn to solve several cases in low back pain
 
Riu008001 0028
Riu008001 0028Riu008001 0028
Riu008001 0028
 
Neuropathic pain: an overview
Neuropathic pain: an overviewNeuropathic pain: an overview
Neuropathic pain: an overview
 
Facet joint cervical
Facet joint cervicalFacet joint cervical
Facet joint cervical
 
00006250 201409000-00021
00006250 201409000-0002100006250 201409000-00021
00006250 201409000-00021
 
PCP AC 2021 - Back Pain Basics
PCP AC 2021 - Back Pain BasicsPCP AC 2021 - Back Pain Basics
PCP AC 2021 - Back Pain Basics
 
Central Neuropathic Pain after Acute Spinal Cord Injury (NP in SCI): A Case s...
Central Neuropathic Pain after Acute Spinal Cord Injury (NP in SCI): A Case s...Central Neuropathic Pain after Acute Spinal Cord Injury (NP in SCI): A Case s...
Central Neuropathic Pain after Acute Spinal Cord Injury (NP in SCI): A Case s...
 
Lynna Nguyen, Final Paper
Lynna Nguyen, Final PaperLynna Nguyen, Final Paper
Lynna Nguyen, Final Paper
 
Predicting Medical Test Results and Intra-Operative Findings in Chronic Pain ...
Predicting Medical Test Results and Intra-Operative Findings in Chronic Pain ...Predicting Medical Test Results and Intra-Operative Findings in Chronic Pain ...
Predicting Medical Test Results and Intra-Operative Findings in Chronic Pain ...
 
Neuropathic pain: epidemiology, risks and prevention
Neuropathic pain: epidemiology, risks and preventionNeuropathic pain: epidemiology, risks and prevention
Neuropathic pain: epidemiology, risks and prevention
 
Experience of a comprehensive pain care (cpc) clinic from a provincial gener...
Experience of a comprehensive pain care (cpc) clinic  from a provincial gener...Experience of a comprehensive pain care (cpc) clinic  from a provincial gener...
Experience of a comprehensive pain care (cpc) clinic from a provincial gener...
 
Impact of migraine_on_fibromyalgia_symptoms
Impact of migraine_on_fibromyalgia_symptomsImpact of migraine_on_fibromyalgia_symptoms
Impact of migraine_on_fibromyalgia_symptoms
 
Aidp dilemmas
Aidp dilemmasAidp dilemmas
Aidp dilemmas
 
Chikv zikv autoimmunity_f
Chikv zikv autoimmunity_fChikv zikv autoimmunity_f
Chikv zikv autoimmunity_f
 
Meta-Analysis of population studies on the prevalence of chronic pain in UK –...
Meta-Analysis of population studies on the prevalence of chronic pain in UK –...Meta-Analysis of population studies on the prevalence of chronic pain in UK –...
Meta-Analysis of population studies on the prevalence of chronic pain in UK –...
 

More from ashokha

Embed code
Embed codeEmbed code
Embed code
ashokha
 
poornamatha : poornamitham poornath-poorna-muthatchyathe |
poornamatha :  poornamitham poornath-poorna-muthatchyathe |poornamatha :  poornamitham poornath-poorna-muthatchyathe |
poornamatha : poornamitham poornath-poorna-muthatchyathe |
ashokha
 
Flyover
FlyoverFlyover
Flyover
ashokha
 
Eso upanishad
Eso upanishadEso upanishad
Eso upanishad
ashokha
 
Elizabeth taylor
Elizabeth taylorElizabeth taylor
Elizabeth taylor
ashokha
 
Eli,அஜ்மல் கசப் ,
Eli,அஜ்மல் கசப் ,Eli,அஜ்மல் கசப் ,
Eli,அஜ்மல் கசப் ,
ashokha
 
Efforts and luck neeyaa naanaa vijay tv
Efforts and luck neeyaa naanaa vijay tvEfforts and luck neeyaa naanaa vijay tv
Efforts and luck neeyaa naanaa vijay tv
ashokha
 
Earth quake
Earth quake Earth quake
Earth quake
ashokha
 
Cudddalore
CudddaloreCudddalore
Cudddalore
ashokha
 
Chanthokya upanishad
Chanthokya upanishadChanthokya upanishad
Chanthokya upanishad
ashokha
 
Central and egmore
Central and egmoreCentral and egmore
Central and egmore
ashokha
 
Brihadaranyaka upanishad
Brihadaranyaka upanishadBrihadaranyaka upanishad
Brihadaranyaka upanishad
ashokha
 
Brahma upanishad
Brahma upanishadBrahma upanishad
Brahma upanishad
ashokha
 
Bio data of kalki
Bio data of kalkiBio data of kalki
Bio data of kalki
ashokha
 
Bible and piple
Bible and pipleBible and piple
Bible and piple
ashokha
 
American citizens and african citizens
American citizens and african citizensAmerican citizens and african citizens
American citizens and african citizens
ashokha
 
Aithereyopanishad
AithereyopanishadAithereyopanishad
Aithereyopanishad
ashokha
 
Air staff salary
Air staff salaryAir staff salary
Air staff salary
ashokha
 
Anantha sakthi kavasam
Anantha sakthi kavasamAnantha sakthi kavasam
Anantha sakthi kavasam
ashokha
 
Anantha sakthi kavasam
Anantha sakthi kavasamAnantha sakthi kavasam
Anantha sakthi kavasamashokha
 

More from ashokha (20)

Embed code
Embed codeEmbed code
Embed code
 
poornamatha : poornamitham poornath-poorna-muthatchyathe |
poornamatha :  poornamitham poornath-poorna-muthatchyathe |poornamatha :  poornamitham poornath-poorna-muthatchyathe |
poornamatha : poornamitham poornath-poorna-muthatchyathe |
 
Flyover
FlyoverFlyover
Flyover
 
Eso upanishad
Eso upanishadEso upanishad
Eso upanishad
 
Elizabeth taylor
Elizabeth taylorElizabeth taylor
Elizabeth taylor
 
Eli,அஜ்மல் கசப் ,
Eli,அஜ்மல் கசப் ,Eli,அஜ்மல் கசப் ,
Eli,அஜ்மல் கசப் ,
 
Efforts and luck neeyaa naanaa vijay tv
Efforts and luck neeyaa naanaa vijay tvEfforts and luck neeyaa naanaa vijay tv
Efforts and luck neeyaa naanaa vijay tv
 
Earth quake
Earth quake Earth quake
Earth quake
 
Cudddalore
CudddaloreCudddalore
Cudddalore
 
Chanthokya upanishad
Chanthokya upanishadChanthokya upanishad
Chanthokya upanishad
 
Central and egmore
Central and egmoreCentral and egmore
Central and egmore
 
Brihadaranyaka upanishad
Brihadaranyaka upanishadBrihadaranyaka upanishad
Brihadaranyaka upanishad
 
Brahma upanishad
Brahma upanishadBrahma upanishad
Brahma upanishad
 
Bio data of kalki
Bio data of kalkiBio data of kalki
Bio data of kalki
 
Bible and piple
Bible and pipleBible and piple
Bible and piple
 
American citizens and african citizens
American citizens and african citizensAmerican citizens and african citizens
American citizens and african citizens
 
Aithereyopanishad
AithereyopanishadAithereyopanishad
Aithereyopanishad
 
Air staff salary
Air staff salaryAir staff salary
Air staff salary
 
Anantha sakthi kavasam
Anantha sakthi kavasamAnantha sakthi kavasam
Anantha sakthi kavasam
 
Anantha sakthi kavasam
Anantha sakthi kavasamAnantha sakthi kavasam
Anantha sakthi kavasam
 

Chikungunya

  • 1. Net news I suffered from this disease a couple of years back. i had severe joint pains and also fever. I consulted a doctor, was given medicines. I took them regularly . The fever stopped but the joint pain was much after that. I suffered for nearly 6 months with the pain. One cannot stand erect after sitting for sometime. It is very dfficult actually. I could resume routine only after 6-8 months. Pain killers on the advise of the dr. is best. Also you could ask your mil to take lots of oranges, it may help. Chikungunya virus (CHIKV) is responsible for major epidemics worldwide. Autochthonous cases were recently reported in several European countries. Acute infection is thought to be monophasic. However reports on chronic pain related to CHIKV infection have been made. In particular, the fact that many of these patients do not respond well to usual analgesics suggests that the nature of chronic pain may be not only nociceptive but also neuropathic. Neuropathic pain syndromes require specific treatment and the identification of neuropathic characteristics (NC) in a pain syndrome is a major step towards pain control. The mean intensity of pain on the visual-analogical scale (VAS) was 5.8 ± 2.1, and its mean duration was 89 ± 2 days. Fifty-six patients fulfilled the definition of chronic pain. Pain had NC in 18.9% according to the DN4 questionnaire. Conversely, about two thirds (65%) of patients with NC had chronic pain. The average pain intensity was similar between patients with or without NC (6.0 ± 1.7 vs 6.1 ± 2.0). However, the total score of the Short Form-McGill Pain Questionnaire (SF-MPQ)(15.5 ± 5.2 vs 11.6 ± 5.2; p < 0.01) and both the affective (18.8 ± 6.2 vs 13.4 ± 6.7; p < 0.01) and sensory subscores (34.3 ± 10.7 vs 25.0 ± 9.9; p < 0.01) were significantly higher in patients with NC. The mean pain interference in life activities calculated from the Brief Pain Inventory (BPI) was significantly higher in patients with chronic pain than in patients without it (6.8 ± 1.9 vs 5.9 ± 1.9, p < 0.05). This score was also significantly higher in patients with NC than in those without such a feature (7.2 ± 1.5 vs 6.1 ± 1.9, p < 0.05). Chikungunya (in the Makonde language "that which bends up") virus (CHIKV) is an insect- borne virus, of the genus Alphavirus, that is transmitted to humans by virus- carrying Aedesmosquitoes.[1] There have been recent outbreaks of CHIKV associated with severe illness. CHIKV causes an illness with symptoms similar to dengue fever. CHIKV manifests itself with an acutefebrile phase of the illness lasting only two to five days, followed by a prolonged arthralgic disease that affects the joints of the extremities. The pain associated with CHIKV infection of the joints persists for weeks or months, or in some cases years.[2][3] The incubation period of Chikungunya disease is from two to four days. Symptoms of the disease include a fever up to 40 °C (104 °F), apetechial or maculopapular rash of the trunk and occasionally the limbs, and arthralgia or arthritis affecting multiple joints.[4] Other nonspecific symptoms can include headache, conjunctival Injection, and slight photophobia. Typically, the fever lasts for two days and then ends abruptly. However, other symptoms—namely joint pain, intense headache, insomnia and an extreme degree of prostration—last for a variable period;
  • 2. usually for about 5 to 7 days.[4] Patients have complained of joint pains for much longer time periods depending on their age.[5][6] Post-Epidemic Chikungunya Disease on Reunion Island: Course of Rheumatic Manifestations and Associated Factors over a 15-Month Period At the 15-month-period evaluation after diagnosis, 84 of 147 participants (57%) self-reported rheumatic symptoms. Of these 84 patients, 53 (63%) reported permanent trouble while 31 (37%) had recurrent symptoms. Age ≥45 years (OR = 3.9, 95% CI 1.7–9.7), severe initial joint pain (OR = 4.8, 95% CI 1.9–12.1), and presence of underlying osteoarthritis comorbidity (OR = 2.9, 95% CI 1.1–7.4) were predictors of nonrecovery. Our findings suggest that long-term CHIKV rheumatic manifestations seem to be a frequent underlying post-epidemic condition. Three independent risk factors that may aid in early recognition of patients with the highest risk of presenting prolonged CHIKV illness were identified. Such findings may be particularly useful in the development of future prevention and care strategies for this emerging virus infection. We found that rheumatic symptoms lasted for at least 15 months in 57% of the participants. Of these, 63% reported permanent trouble while 37% had recurrent symptoms. Factors such as age ≥45 years, severe initial joint pain, and presence of underlying osteoarthritis comorbidity were associated with nonrecovery over the 15-month period. Our findings suggest that long- term CHIKV rheumatic manifestations seem to be a hidden, frequent, post-epidemic condition. These findings should be considered in the development of preventive measures. Chikungunya fever, an emerging mosquito-borne viral disease, has affected Mauritius with two recent outbreaks in 2005 and 2006 respectively. A study was carried out in 2007 to describe the clinical complications post-Chikungunya infection. Ethical clearance was obtained for this study. Data collection was carried out in February and March 2007 on a sample of people who had suffered from Chikungunya fever by means of a comprehensive questionnaire. Participants comprised 77 people; there were 41 males and 36 females. Participants ranged from 6 to 69 years. 70 participants experienced persisting joint pains for at least 6 months following the acute phase. Of these, 35 had residual joint complaints after 6 months. 44 participants suffered from psychological sequelae. 10 participants had dermatological sequelae, 6 had iatrogenic complications due to non-steroidal anti-inflammatory drug (NSAID)-induced gastritis, and 3 participants with serologically confirmed Chikungunya fever had neurological manifestations and changes on CT/MRI which could correspond to demyelination. Statistical analysis demonstrated that there was a weak linear relationship between the number of complications and increasing age; there was a significant difference in the number of complications according to gender, females being more affected than males; participants with co-morbidities had more complications and psychological sequelae than previously healthy participants. This study highlights that Chikungunya fever, which causes a significant impact on health in the acute phase, can have significant sequelae months afterwards and this includes psychological sequelae.
  • 3. Chikungunya or unknown viral fever I have Chikungunya fever during December 2009. Doctor describes it as viral fever and give some medicines. Fever gone but the pain persists even after three months. The fever is having all the symptoms that are described in net sites. The Chikungunya will be there only for three or four days. My fever has gone on fourth day. It will reach 104 degrees. I have 104 degrees for two days. Chikungunya ends abruptly for ordinary medicines. I have taken paracetamol and declofenac and the fever ends. Rheumatic pain will be there even upto six months. I am still have pain even after three months. It is epidemic and spreads quickly. During december and january in my town alone each and every house has four or five patients. But doctors say this is not Chikungunya but an unknown viral fever. Government doctors also repeat the same. One doctor describes it as a cross breeding of denque and Chikungunya. So it is undoubtedly the notorius Chikungunya. But even the newspapers and TV channels describe it as unknown viral fever. Government declares that there is an unidentified viral fever and it is not Chikungunya and research is going on to find what it is. But according to common men who is standing with the knee bending it is Chikungunya and say “I am having Chikungunya for the past three months” when they describe their sufferings. My doubt is why the media and the Government hesitate to declare that it is Chikungunya. Whether the World Health Organisation (W.H.O) will declare the country as ugly country if it has Chikungunya? Or whether the World Bank will refuse to give loans to the country if Chikungunya is there in that country? Or whether the opposing party members will cry that the Government has failed to control an epidemic decease in Parliament and in Assembly? God only knows..... But the pain and the doubt persist............